Warning
DermaRite Industries Recalls Renew PeriProtect
This is a Class II recall. This product may cause temporary health problems or pose a slight threat of a serious nature.
Source: FDA
WarningRecall #D-0174-2026Drug / Pharmaceutical
DermaRite Industries Recalls Renew PeriProtect
DermaRite Industries, LLC · Class II — Moderate Risk
Product Description
Renew PeriProtect, Zinc Oxide 12%, Dimethicone 1%, 113g (4 oz.) per tube, DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047. NDC 61924-435-04
Reason for Recall
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
FDA Classification
Class II — Moderate Risk
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Distribution
Nationwide in the USA
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
A Class II FDA recall has been issued for a pharmaceutical product from DermaRite Industries, LLC, initiated on August 27, 2025. CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated. This recall covers 37,272 tubes, distributed nationwide. While not the highest severity, consumers should exercise caution and stop using the product until the recall is resolved.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medical Product Contamination and DermaRite Industries recalls.